Next Article in Journal
2-Methyl-3-{4-[2-(1H-tetrazol-5-yl)ethylamino]phenyl}-3H-quinazolin-4-one
Previous Article in Journal
4,6-Diamino-5-(3,4-dichlorobenzylidene)pyrimidin-2(5H)-one
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2E,2'E-3,3'-(1,4-Phenylene)bis(1-(2,5-dimethylfuran-3-yl)prop-2-en-1-one

by
Abdullah M. Asiri
1,2,* and
Salman A. Khan
1
1
Chemistry Department, Faculty of Science, King Abdul Aziz University, P.O. Box 80203, Jeddah, Saudi Arabia
2
The Center of Excellence for Advanced Materials Research, King Abdul Aziz University, Jeddah, P.O. Box 80203, Saudi Arabia
*
Author to whom correspondence should be addressed.
Molbank 2010, 2010(3), M694; https://doi.org/10.3390/M694
Submission received: 8 July 2010 / Accepted: 14 September 2010 / Published: 15 September 2010

Abstract

:
A bis-chalcone has been synthesized by reaction of 3-acetyl-2,5-dimethylfuran and terephthalaldehyde in ethanolic NaOH at room temperature: (2E,2'E)-3,3'-(1,4-phenylene)bis(1-(2,5-dimethylfuran-3-yl)prop-2-en-1-one) (3) was obtained in high yield. The structure of this compound was established by elemental analysis, IR, 1H NMR, 13C NMR and EI-MS spectral analysis.

Graphical Abstract

The Claisen-Schmidt condensation is the most important reaction for the formation of 1,3-diphenyl-2-propene-1-ones. The products, also known as chalcones, generally are synthesized by this method from suitable acetophenones and benzaldehydes. Chalcones are considered to be precursors of flavonoids when found as naturally-occurring compounds. The chemical importance of chalcones is extended in two branches: their biological activity, including anti-inflammatory [1], antimitotic [2], anti-leishmanial [3], anti-invasive [4], anti fungal [5], antimalarial [6] and anti-tumor [7] properties; as well as their recognized synthetic utility in the preparation of pharmacologically interesting hetero­cyclic systems such as thiazines, pyrimidines, and pyrazoles. Here we are reporting a novel bis-chalcone prepared from 3-acetyl-2,5-dimethylfuran and terephthalaldehyde. The product is assumed to exist as one E,E-diastereomer, since in the the 1H-NMR spectrum the olefinic protons display coupling constants of 15.6 Hz indicative of the E-configuration.
A solution of 3-acetyl-2,5-dimethylfuran (2.34 mL, 0.028 mol) and terephthalaldehyde (2.0 g, 0.014 mol) in an ethanolic solution of NaOH (6.0 g in 10 mL of ethanol) was stirred for 20 h at room temperature. The solution was poured into ice cold water of pH~2 (pH adjusted by HCl). The solid was separated and dissolved in CH2Cl2, washed with a saturated solution of NaHCO3 and evaporated to dryness. The residue was recrystallized from methanol/chloroform to give a yellow solid:
Yield: 78%; m.p. 182 °C.
EI-MS m/z (rel. int.%): 376 (76) [M+1]+,
IR (KBr) vmax cm−1: 2956 (C-H), 1655 (C=O), 1567 (C=C).
1H NMR (600 MHz, CDCl3) δ: 7.72 (d, 2H, J = 15.6 Hz, C=CH), 7.22 (d, 2H, J = 15.6 Hz, CO=CH), 7.63 (s, 4H, Ar-H), 6.34 (s, 2H, 2×furan-H), 2.62 (s, 6H, 2×CH3), 2.30 (s, 6H, 2×CH3).
13CNMR (150 MHz, CDCl3) δ: 185.65, 158.20, 150.17, 141.60, 136.70, 128.99, 125.00, 122.41, 105.54, 14.53, 13.05.
Anal. calc. for C24H22O4: C, 76.99, H, 5.92, O, 17.09; Found: C, 76.95, H, 5.88, O, 19.98.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

Acknowledgements

The authors would like to thank the deanship of scientific research for the financial support of this work via Grant No. (3-045/430).

References

  1. Vogel, S.; Barbic, M.; Jurgenliemk, G.; Heilmann, J. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect. Eur. J. Med. Chem. 2010, 45, 2206–2213. [Google Scholar] [CrossRef] [PubMed]
  2. Kamal, A.; Balakishan, G.; Ramakrishna, G.; Shaik, T.B.; Sreekanth, K.; Balakrishna, M.; Rajender, D.; Kalivendi, S.V. Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents. Eur. J. Med. Chem. 2010, 45, 3870–3884. [Google Scholar] [CrossRef] [PubMed]
  3. Reichwald, C.; Shimony, O.; Sacerdoti-Sierra, N.; Jaffe, C.L.; Kunick, C. A new Heck reaction modification using ketone Mannich bases as enone precursors: Parallel synthesis of anti-leishmanial chalcones. Bioorg. Med. Chem. Lett. 2008, 18, 1985–1989. [Google Scholar] [CrossRef] [PubMed]
  4. Katritzky, A.R.; Kuanar, M.; Dobchev, D.A.; Vanhoecke, B.W.A.; Karelson, M.; Parmar, V.S.; Stevens, C.V.; Bracke, M.E. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors. Bioorg. Med. Chem. 2006, 14, 6933–6939. [Google Scholar] [CrossRef] [PubMed]
  5. Hussain, T.; Siddiqui, H.L.; Zia-ur-Rehman, M.; Yasinzai, M.M.; Parvez, M. Anti-oxidant, anti-fungal and anti-leishmanial activities of novel 3-[4-(1H-imidazol-1-yl) phenyl]prop-2-en-1-ones. Eur. J. Med. Chem. 2009, 44, 4654–4660. [Google Scholar] [CrossRef] [PubMed]
  6. Wu, X.; Wilairat, P.; Go, M. Antimalarial activity of ferrocenyl chalcones. Bioorg. Med. Chem. Lett. 2002, 12, 2299–2302. [Google Scholar] [CrossRef]
  7. Rao, Y.K.; Fang, S.; Tzeng, Y. Synthesis, growth inhibition, and cell cycle evaluations of novel flavonoid derivatives. Bioorg. Med. Chem. 2005, 13, 6850–6855. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Synthesis of compound 3.
Figure 1. Synthesis of compound 3.
Molbank 2010 m694 g001

Share and Cite

MDPI and ACS Style

Asiri, A.M.; Khan, S.A. 2E,2'E-3,3'-(1,4-Phenylene)bis(1-(2,5-dimethylfuran-3-yl)prop-2-en-1-one. Molbank 2010, 2010, M694. https://doi.org/10.3390/M694

AMA Style

Asiri AM, Khan SA. 2E,2'E-3,3'-(1,4-Phenylene)bis(1-(2,5-dimethylfuran-3-yl)prop-2-en-1-one. Molbank. 2010; 2010(3):M694. https://doi.org/10.3390/M694

Chicago/Turabian Style

Asiri, Abdullah M., and Salman A. Khan. 2010. "2E,2'E-3,3'-(1,4-Phenylene)bis(1-(2,5-dimethylfuran-3-yl)prop-2-en-1-one" Molbank 2010, no. 3: M694. https://doi.org/10.3390/M694

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop